Pfizer site manufacturing heparin active pharmaceutical ingredient. Pfizer is a pharmaceutical biotechnology corporation. U.S. government regulators have approved a new brain tumor warning for ...

The U.S. Food and Drug Administration (FDA) has updated the warning label for the Depo-Provera birth control shot to include information about the risk of meningioma brain tumors. The label update is ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

The label revision follows emerging evidence linking long-term use of Depo-Provera (medroxyprogesterone acetate) to a higher likelihood of developing meningiomas — tumors that, while often benign, can ...

-- Global pharmaceutical company Pfizer Inc. (NYSE: PFE), manufacturer of contraceptive injection Depo-Provera (DMPA), is facing a Multidistrict Litigation (MDL No. 3140) in the USA being brought on ...

Depo Provera Brain Tumor: Medroxyprogesterone acetate, a contraceptive injection containing the hormone progestin, is widely known by its brand name, Depo-Provera. Administered every three months, it ...

"It could be big. I think it could be as big as some of the others we've gotten here," Anapol Weiss shareholder Kila Baldwin said. In March, neurosurgeons and researchers in France published a large ...

Nov. 22, 2004 — The U.S. Food and Drug Administration (FDA) and Pfizer have notified healthcare professionals via letter of revisions to the safety labeling for medroxyprogesterone acetate (MPA) ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

PENSACOLA, Fla.--(BUSINESS WIRE)-- At a Case Management Conference in the Multi District Litigation against Pfizer Inc., the Honorable M. Casey Rodgers set a date for the first Trial, which will take ...

Key Takeaways U.S. government regulators have approved a new brain tumor warning for Depo-ProveraLawsuits from more than 1,000 women claim they weren’t warned soonerRegulators in Europe and Canada ...